Adjuvant and neoadjuvant therapy with cyclin-dependent kinase 4 and 6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer: a systematic review and meta-analysis.

Zhang, Meilin; Song, Jian; Guo, Shigang; Jin, Feng; Zheng, Ang

Zhang, Meilin; Song, Jian; Guo, Shigang; Jin, Feng; Zheng, Ang.

Afiliação

Zhang M; Department of Burn and Plastic Surgery, Chaoyang Central Hospital, Chaoyang, Liaoning Province, China.
Song J; Department of Breast Surgery, the First Hospital of China Medical University, Shenyang, Liaoning Province, China.
Guo S; Department of General Surgery, Chaoyang Central Hospital, Chaoyang, Liaoning Province, China.
Jin F; Department of Breast Surgery, the First Hospital of China Medical University, Shenyang, Liaoning Province, China.
Zheng A; Department of Breast Surgery, the First Hospital of China Medical University, Shenyang, Liaoning Province, China.

Endocr Relat Cancer ; 30(8)2023 08 01.

Article em En | MEDLINE | ID: mdl-37283514

Assuntos

Neoplasias da Mama; Terapia Neoadjuvante; Feminino; Humanos; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Neoplasias da Mama/patologia; Quinase 4 Dependente de Ciclina/antagonistas & inibidores; Recidiva Local de Neoplasia; Receptor ErbB-2/metabolismo; Inibidores de Proteínas Quinases/uso terapêutico

Palavras-chave

CDK4/6 inhibitors; early breast cancer; endocrine therapy; randomized controlled trial

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Endocr Relat Cancer Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google